mitoxantrone (Compound)

Synonyms:mitoxantrone, 65271-80-9, Mitoxanthrone, Mitozantrone, DHAQ, Mitoxantron, Novantrone, Mitoxantrona, Mitoxantronum, Mitoxantrone [INN], Misostol, NSC 279836, NSC-279836, DHAD, NSC279836, 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione, Mitoxantrone (INN), Mitoxantrone free base, 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone, BZ114NVM5P, 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone, 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE, MLS002703044, CHEBI:50729, 65271-80-9 (free base), MFCD00242942, 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-, Mitoxantronum [INN-Latin], Mitoxantrona [INN-Spanish], NSC299195, NSC301739, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione, 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione, ANTHRAQUINONE, 5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-1,4-DIHYDROXY-, 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione, MIX, 1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione, MLS001333711, 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-, Misostol (TN), CCRIS 7604, NCGC00015693-02, Mitoxantrone (free base), SMR000058480, Mitoxantrone [INN:BAN], CAS-70476-82-3, UNII-BZ114NVM5P, DHAQ (*Diacetate salt*), BRN 2795126, SR-01000076001, Mitoxantrone base, 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon, 2fum, 1,4-dihydroxy-5,8-bis(2-(2-hydroxyethylamino)ethylamino)anthracene-9,10-dione, 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione, Immunex (Salt/Mix), Spectrum_001655, CHEMBL58, Prestwick0_000385, Prestwick1_000385, Prestwick2_000385, Prestwick3_000385, Spectrum2_000908, Spectrum3_001590, Spectrum4_000866, Spectrum5_001205, Lopac-M-6545, MITOXANTRONE [MI], MITOXANTRONE [IARC], cid_4212, Neuro_000153, SCHEMBL3000, 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone, MITOXANTRONE [VANDF], BIDD:PXR0181, Lopac0_000779, BSPBio_000569, BSPBio_003160, KBioGR_001531, KBioSS_002135, DivK1c_000516, MITOXANTRONE [WHO-DD], SPBio_000756, SPBio_002490, BPBio1_000627, GTPL7242, DTXSID4046947, BDBM67690, cid_5458171, KBio1_000516, KBio2_002135, KBio2_004703, KBio2_007271, KBio3_002660, NINDS_000516, HMS2090D05, HMS3655E20, KUC108634N, BCP02861, CCG-36371, s1889, STK631833, Mitoxantrone hydrochloride (Salt/Mix), AKOS005564036, BCP9000931, DB01204, KSC-19-204, SDCCGSBI-0050757.P004, IDI1_000516, SMP2_000179, NCGC00015693-01, NCGC00015693-03, NCGC00015693-04, NCGC00015693-05, NCGC00015693-06, NCGC00015693-08, NCGC00015693-13, NCGC00015693-23, NCGC00162251-01, AS-35321, HY-13502, MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE, NCI60_002276, NCI60_002535, SMR001549953, SY226320, SBI-0050757.P003, AB00053716, FT-0630752, FT-0672423, M3133, SW196745-6, VU0244399-2, D08224, EN300-117257, AB00053716-18, AB00053716-19, AB00053716-22, AB00053716_23, AB00053716_24, Q239426, SR-01000076001-7, BRD-K21680192-001-01-5, BRD-K21680192-001-11-4, BRD-K21680192-300-05-2, BRD-K21680192-300-07-8, BRD-K21680192-300-09-4, BRD-K21680192-300-10-2, BRD-K21680192-300-12-8, 1,4-bis[2-(2-hydroxyethylamino)-ethylamino]-5,8-dihydroxyanthraquinone, 1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-dihydroxyanthraquinone, 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone, 9, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl] amino]-, 1,4-Bis[[2-[(2-hydroxyethyl)amino]ethyl]imino]-1,4-dihydroanthracene-5,8,9,10-tetrol, 1,4-Dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone;hydrochloride, 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;hydrochloride, 1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione;hydrochloride, MITOXANTRONE; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE
Pubchem:PUBCHEM:4212
Id:c15ca8cc-027a-5137-9173-ec1c7fb2294d
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View mitoxantrone's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for mitoxantrone.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with mitoxantrone.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.